| |
|
| |
| THE GENERAL ASSEMBLY OF PENNSYLVANIA |
| |
| SENATE BILL |
|
| |
| |
| INTRODUCED BY GREENLEAF, FONTANA, WILLIAMS, ERICKSON, STOUT, MUSTO, FOLMER, BRUBAKER, ALLOWAY, M. WHITE, FERLO, COSTA, EARLL, WAUGH, O'PAKE, LEACH, WONDERLING AND STACK, JANUARY 30, 2009 |
| |
| |
| REFERRED TO CONSUMER PROTECTION AND PROFESSIONAL LICENSURE, JANUARY 30, 2009 |
| |
| |
| |
| AN ACT |
| |
1 | Amending the act of September 27, 1961 (P.L.1700, No.699), |
2 | entitled "An act relating to the regulation of the practice |
3 | of pharmacy, including the sales, use and distribution of |
4 | drugs and devices at retail; and amending, revising, |
5 | consolidating and repealing certain laws relating thereto," |
6 | further providing for refusal to grant and revocation and |
7 | suspension of licenses; and providing for the donation of |
8 | unused prescription drugs. |
9 | The General Assembly of the Commonwealth of Pennsylvania |
10 | hereby enacts as follows: |
11 | Section 1. Section 5(a)(9) of the act of September 27, 1961 |
12 | (P.L.1700, No.699), known as the Pharmacy Act, amended December |
13 | 20, 1985 (P.L.433, No.111), is amended to read: |
14 | Section 5. Refusal to Grant, Revocation and Suspension.--(a) |
15 | The board shall have the power to refuse, revoke or suspend the |
16 | license of any pharmacist upon proof satisfactory to it that the |
17 | pharmacist: |
18 | * * * |
19 | (9) Is guilty of grossly unprofessional conduct. The |
|
1 | following acts on the part of a pharmacist are hereby declared |
2 | to constitute grossly unprofessional conduct of a pharmacist: |
3 | (i) Willfully deceiving or attempting to deceive the State |
4 | Board of Pharmacy or its agents with respect to any material |
5 | matter under investigation by the board; |
6 | (ii) Advertising of prices for drugs and pharmaceutical |
7 | services to the public which does not conform to Federal laws or |
8 | regulations; |
9 | (iii) The public assertion or implication of professional |
10 | superiority in the practice of pharmacy; |
11 | (iv) The engaging by any means in untrue, false, misleading |
12 | or deceptive advertising of drugs or devices; |
13 | (v) Paying rebates to physicians or any other persons, or |
14 | the entering into any agreement with a medical practitioner or |
15 | any other person for the payment or acceptance of compensation |
16 | in any form for the recommending of the professional services of |
17 | either party; |
18 | (vi) The entering into of any agreement with a licensed |
19 | medical practitioner for the compounding or dispensing of secret |
20 | formula (coded), prescriptions; |
21 | (vii) The misbranding or adulteration of any drug or device |
22 | and the sale, distribution or dispensing of any misbranded or |
23 | adulterated drug or device as defined in the act of April 14, |
24 | 1972 (P.L.233, No.64), known as "The Controlled Substance, Drug, |
25 | Device and Cosmetic Act"; |
26 | (viii) Engaging in the sale or purchase of drugs or devices |
27 | whose package bears the inscription "sample" or "not for |
28 | resale;" |
29 | (ix) Displaying or permitting the display of his certificate |
30 | of licensure and biennial registration document in a pharmacy of |
|
1 | which he is not the proprietor or in which he is not employed; |
2 | (x) Any holder of a biennial pocket registration card who |
3 | fails to have the card available for inspection by an authorized |
4 | agent when he is practicing; |
5 | (xi) The acceptance back and redistribution of any unused |
6 | drug, or a part thereof, except as authorized under section 9.3 |
7 | of this act, after it has left the premises of any pharmacy, |
8 | whether issued by mistake or otherwise, unless it is in the |
9 | original sealed container with the name, lot number and |
10 | expiration date on the original intact manufacturer's label. The |
11 | pharmacy shall maintain records of all such returns, and a full |
12 | refund shall be given to the original purchaser, including a |
13 | third-party payor; |
14 | (xii) To accept employment as a pharmacist, or share or |
15 | receive compensation in any form arising out of, or incidental |
16 | to, his professional activities from any medical practitioner or |
17 | any other person or corporation in which one or more medical |
18 | practitioners have a proprietary or beneficial interest |
19 | sufficient to permit them to exercise supervision or control |
20 | over the pharmacist in his professional responsibilities and |
21 | duties; |
22 | (xiii) To accept employment as a pharmacist, or share or |
23 | receive compensation in any form arising out of, or incidental |
24 | to, his professional activities from any person who orders said |
25 | pharmacist, directly or indirectly, to engage in any aspect of |
26 | the practice of pharmacy in contravention of any provision of |
27 | this act. |
28 | * * * |
29 | Section 2. The act is amended by adding a section to read: |
30 | Section 9.3. Donation of Unused Prescription Drugs.--(a) |
|
1 | The Department of Health, the board and the Health Care Cost |
2 | Containment Council shall jointly develop and implement a pilot |
3 | program consistent with public health and safety through which |
4 | unused prescription drugs, other than drugs that are controlled |
5 | dangerous substances, may be transferred from nursing facilities |
6 | to pharmacies operated by the Commonwealth for the purpose of |
7 | distributing the prescription drugs to residents who are |
8 | medically indigent. |
9 | (b) The Department of Health, the board, the Health Care |
10 | Cost Containment Council, the State Board of Medicine and the |
11 | State Board of Osteopathic Medicine shall review and evaluate |
12 | the program no later than eighteen months after its |
13 | implementation and shall submit a report and any recommendations |
14 | to the Governor, the President pro tempore of the Senate, the |
15 | Speaker of the House of Representatives and the chairmen of the |
16 | appropriate legislative committees. |
17 | (c) The Department of Health, the board and the Health Care |
18 | Cost Containment Council shall promulgate rules and establish |
19 | procedures necessary to implement the program established by |
20 | this section. The rules and procedures shall provide: |
21 | (1) For a formulary for the medications to be distributed |
22 | pursuant to the program. |
23 | (2) For the protection of the privacy of the individual for |
24 | whom the medication was originally prescribed. |
25 | (3) For the integrity and safe storage and safe transfer of |
26 | the medication, which may include, but shall not be limited to, |
27 | limiting the drugs made available through the program to those |
28 | that were originally dispensed by unit dose or an individually |
29 | sealed dose or which remain in intact packaging. |
30 | (4) For the tracking of and accountability for the |
|
1 | medications. |
2 | (5) For other matters necessary for the implementation of |
3 | the program. |
4 | (d) In accordance with the rules and procedures of a program |
5 | established pursuant to this section, the resident of a nursing |
6 | facility or the representative or guardian of a resident may |
7 | donate unused prescription drugs, other than prescription drugs |
8 | that are controlled dangerous substances, for dispensation to |
9 | residents who are medically indigent. |
10 | (e) No physician, pharmacist and other health care |
11 | professional shall be subject to liability for participation in |
12 | the program established by this section when acting within the |
13 | scope of practice of his license and in good faith compliance |
14 | with the rules promulgated pursuant to this section. |
15 | (f) For purposes of this section, "persons who are medically |
16 | indigent" means persons who have no health insurance or who |
17 | otherwise lack reasonable means to purchase prescribed |
18 | medications. |
19 | Section 3. This act shall take effect in 60 days. |
|